On February 9, 2026, the group standard High-Throughput Sequencing Detection Method for Gene Variants Related to Non-Small Cell Lung Cancer Based on Circulating Tumor DNA Samples (Standard No.: T/GRHA 0002—2026) was officially released by the Guangdong Respiratory and Health Society. Led by KingMed Diagnostics, iGeneTech participated as an upstream kit manufacturer.
The release of this group standard marks a key achievement of close collaboration among three parties. KingMed Diagnostics provided practical support for standard implementation with extensive clinical experience and a comprehensive testing service system. Several top-tier tertiary hospitals contributed massive real-world clinical data based on in-depth clinical expertise, ensuring the standard aligns with real clinical needs.
As an upstream capture kit provider, iGeneTech leveraged over a decade of technical accumulation in genetic testing, including a full-chain core technology system covering massively parallel Oligo Pool synthesis, probe & primer design, and hybrid capture sequencing. It delivered a full-process testing solution adaptable to various clinical laboratories and testing institutions.
Product & Workflow
Custom Panel Synthesis & Delivery: 3-4 days
Sample Extraction: Enhanced magnetic-bead method for efficient recovery; supports up to 4 mL plasma per run for rapid, high-efficiency extraction
Library Preparation: IGT™ Fast Library Prep Kit v2.0 with UMI & UDI; ultra-high molecular recovery ensures efficient DNA utilization
Capture: TargetSeq One v3.0 & TargetSeq Universal Blocker; compatible with all probe types, supports fast hybridization (as short as 30 min) for efficient, stable capture
Data Analysis: Dedicated UMI bioinformatics analysis pipeline
Automation Solutions
IGT-AS12 Automated Workstation (mid-throughput): Preloaded with standardized experimental protocols; ready to use after calibration; paired with pre-mixed reagent strips for simple, fast operation
IGT-AS01 Portable Modular NGS Workstation: All-in-one “load-and-run” system; integrates library preparation and hybrid capture; single-sample independent operation with physical isolation to eliminate cross-contamination; compact footprint (0.1 ㎡, 34 cm height) for biosafety cabinets; scalable via matrix expansion
IGT-AS96 Automated Workstation for high-throughput scenarios
By co-developing the group standard, the three parties demonstrate their technological strengths and follow the inevitable trend of industrial collaboration. Moving forward, iGeneTech will continue to leverage its technical advantages, deepen cooperation, and iterate products and solutions guided by standards. We will promote innovation and upgrading of testing technologies, build a standardized, high-quality in vitro diagnostic ecosystem with partners, and deliver more accurate and efficient testing solutions for clinical practice.
CN
